Abstract
Mucosal melanoma is a relatively rare tumour of the head and neck with a very poor prognosis. Managing this disease entity becomes more difficult due to high chances of disease failure locoregionally and at distant sites. This study assessed the treatment outcomes and factors affecting prognosis of head and neck mucosal melanomas. Forty-one cases of mucosal melanomas of head and neck (MMHN) treated in our institution during 10 years were retrospectively reviewed. Data regarding the clinicopathological parameters and treatment outcomes was collected. Survival was calculated using Kaplan-Meier method. The most common subsite of MMHN was upper alveolus and hard palate (39%). Thirty-one of the 41 cases underwent surgery whereas 10 cases were treated with palliative intent. At presentation, 15 of 41 cases had lymph node involvement and majority of them had primary in the oral cavity: sinonasal region had low chances of lymph node metastasis. Seventy-four percent of cases underwent adjuvant post-operative radiotherapy. For surgically treated cases, 5-year disease-specific survival (DSS) was 35.7%. Mucosal melanomas of nose and paranasal sinuses had a better overall survival than oral cavity. Distant metastasis was the most common cause of disease failure in 12 of 24 cases and had a significant association with disease-specific survival. The stage of the disease was a significant prognostic indicator. Sinonasal cavity mucosal melanomas have a better prognosis than mucosal melanomas in other subsites. Overall survival for surgically treated cases was significantly better than cases treated non-surgically. Presence of lymph node metastasis reduced the survival by 50% in MMHN.
Similar content being viewed by others
References
Weber CO (1859) Surgical experience and research, in addition to interesting observations from the Surgical Clinic and the Protestant Hospital Bonn. G. Reimer, Berlin, pp 304–305
Lourenco SV, Sangueza AM, Sotto MN et al (2009) Primary oral mucosal melanoma: a series of 35 new cases from South America. Am J Dermatopathol 31:323–330
Moreno MA, Roberts DB, Kupferman ME et al (2010) Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D Anderson Cancer Center. Cancer 116:2215–2223
Jangard M, Hansson J, Ragnarsson-Olding B (2013) Primary sinonasal malignant melanoma: a nationwide study of the Swedish population, 1960–2000. Rhinology. 51:22–30
McLaughlin CC, Wu XC, Jemal A et al (2005) Incidence of noncutaneous melanomas in the U.S. Cancer 103:1000–1007
Holmstrom M, Lund VJ (1991) Malignant melanomas of the nasal cavity after occupational exposure to formaldehyde. Br J Ind Med 48:9–11
Satzger I, Schaefer T, Kuettler U, Broecker V, Voelker B, Ostertag H, Kapp A, Gutzmer R (2008) Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas. Br J Cancer 99:2065–2069
Lourenco SV, Fernandes JD, Hsieh R et al (2014) Head and neck mucosal melanoma: a review. Am J Dermatopathol 36:578–587
Turri-Zanoni M, Medicina D, Lombardi D et al (2013) Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases. Head Neck 35:1066–1077
Suzuki N, Onda T, Yamamoto N, Katakura A, Mizoe JE, Shibahara T (2007) Mutation of the p16/CDKN2gene and loss of heterozygosity in malignant mucosal melanoma and adenoid cystic carcinoma of the head and neck. Int J Oncol 31:1061–1067
Hsieh R, Nico MM, Coutinho–Camillo CM, et al. The CDKN2A and MAP kinase pathways: molecular roads to primary oral mucosal melanoma. Am J Dermatopathol 2013; 35:167–175
Tanaka N, Odajima T, Mimura M, Ogi K, Dehari H, Kimijima Y, Kohama G (2001) Expression of Rb, pRb2/p130, p53, and p16 proteins in malignant melanoma of oral mucosa. Oral Oncol 37:308–314
Patel SG, Prasad ML, Escrig M, Singh B, Shaha AR, Kraus DH, Boyle JO, Huvos AG, Busam K, Shah JP (2002) Primary mucosal malignant melanoma of the head and neck. Head Neck. 24:247–257
Mendenhall WM, Amdur RJ, Hinerman RW, Werning JW, Villaret DB, Mendenhall NP (2005) Head and neck mucosal melanoma. Am J Clin Oncol 28:626–630
Guevara-Canales JO, Gutiérrez-Morales MM, Sacsaquispe-Contreras SJ et al (2012) Malignant melanoma of the oral cavity. Review of the literature and experience in a Peruvian population. Med Oral Patol Oral Cir Bucal 17:206–211
Umeda M, Shimada K (1994) Primary malignant melanoma of the oral cavity—its histological classification and treatment. Br J Oral Maxillofac Surg 32:39–47
Terada T, Saeki N, Toh K, Uwa N, Sagawa K, Mouri T, Sakagami M (2007) Primary malignant melanoma of the larynx: a case report and literature review. Auris Nasus Larynx 34:105–110
Franchi A, Alos L, Gale N, Massi D, Paglierani M, Santucci M, Zidar N, Cardesa A (2006) Expression of p16 in sinonasal malignant melanoma. Virchows Arch 449:667–672
Medina JE, Ferlito A, Pellitteri PK, Shaha AR, Khafif A, Devaney KO, Fisher SR, O'Brien CJ, Byers RM, Robbins KT, Pitman KT, Rinaldo A (2003) Current management of mucosal melanoma of the head and neck. J Surg Oncol 83:116–122
Krengli M, Masini L, Kaanders JH et al (2006) Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A rare cancer network study. Int J Radiat Oncol Biol Phys 65:751–759
Nandapalan R, Helliwell et al (1998) Mucosal melanoma of the head and neck. Clin Otolaryngol Allied Sci 23:107–116
Bartell HL, Bedikian AY, Papadopoulos NE, Dett TK, Ballo MT, Myers JN, Hwu P, Kim KB (2008) Biochemotherapy in patients with advanced head and neck mucosal melanoma. Head Neck 30:1592–1598
Ives NJ, Stowe RL, Lorigan P et al (2007) Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients. J Clin Oncol 25:5426–5434
Bajetta E, Del Vecchio M, Nova P et al (2006) Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma. Ann Oncol 17:571–577
Valsecchi ME, Sato T (2013) The potential role of sunitinib targeting melanomas. Expert Opin Investig Drugs 22:1473–1483
Carvajal RD, Antonescu CR, Wolchok JD, Chapman PB, Roman RA, Teitcher J, Panageas KS, Busam KJ, Chmielowski B, Lutzky J, Pavlick AC, Fusco A, Cane L, Takebe N, Vemula S, Bouvier N, Bastian BC, Schwartz GK (2011) KIT as a therapeutic target in metastatic melanoma. JAMA. 305:2327–2334
Plavc G, But-Hadzic J, Anicin A et al (2016) Mucosal melanoma of the head and neck: a population-based study from Slovenia, 1985-2013. Radiat Oncol 11:137
Acknowledgements
We take this opportunity to thank the faculty, fellows, post graduates and staff of the Department of Head & Neck Surgery for their whole-hearted cooperation in completion of this study. We also express our gratitude to the staff of the medical records department for providing us case records to acquire data for this study.
Funding
There is no funding for this research work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Statement
There was adherence to the ethical standards in this study.
Conflict of Interest
The authors declare that they have no conflict of interest (Financial / Non-financial).
Institutional Review Board Approval
All procedures performed in studies were in accordance with the IRB standards of Regional Cancer Centre, Thiruvanathapuram approved by the Institutional Review Board.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Suresh, S., George, N.A., Janardhan, D. et al. Mucosal Melanomas of the Head and Neck—a Tertiary Cancer Centre Experience. Indian J Surg 82, 625–631 (2020). https://doi.org/10.1007/s12262-020-02082-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-020-02082-5